T/FIF Portfolio Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF Portfolio

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Larry Liebman who wrote (991)	6/20/1999 12:50:00 PM
From: scaram(o)uche	Read Replies (1) of 1073

Larry: SUPG..... I'll defer to Peter. They've shown that they can get a job done with Nipent, but that'll make enough for a cup of coffee on occasion. From what I've seen, they're keeping the topo inhibitor on track. Claims that a topo inhibitor has no toxicity are pretty silly, but each company has to make its own decisions about how to relate toxicity to patient benefit and to the problems encountered with other drugs. First right of refusal to anything from Stehlin. I owned some shares for a few minutes a couple of months ago. Apart from that, I haven't stuck toe in. I prefer to focus on companies that have independent, in-house research. Marc was at the last Bay Area Informed Investors forum, so he may have comments? Also, I imagine that one of those Vcall thingies is still available for an even more recent presentation? Rick

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next